Drexel University College of Medicine
Philadelphia, Pennsylvania, United States
Medical school in Philadelphia, Pennsylvania
2900 W Queen Ln, Philadelphia, PA 19129
About Drexel University College of Medicine
Drexel University College of Medicine is the medical school of Drexel University. The medical school represents the consolidation of two medical schools: the first U.S. medical school for women and the nation's first college of homeopathy.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
7
Celgene
5
Boston Scientific Corporation
4
Gilead Sciences
4
Knopp Biosciences
4
Reproductive Research Technologies, LP
4
Vital Therapies, Inc.
4
Abbott Medical Devices
3
Bristol-Myers Squibb
3
Celgene Corporation
3
Drexel University
3
Clinical Trials at Drexel University College of Medicine
During the past decade, Drexel University College of Medicine conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 58 clinical trials were completed, i.e. on
average, 263.6% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 25 clinical trials were completed. i.e. 2500%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study to Evaluate the Safety and Effectiveness of WF10 Given to Patients With Late-Stage HIV Disease
Completed
240
Safety and Effectiveness of PEG-Intron in HIV-Infected Patients
2000-03-01
2000-09-01
Completed
250
T-20 With Anti-HIV Combination Therapy for Patients With Prior Anti-HIV Drug Treatment and/or Drug Resistance to Each of the Three Classes of Approved Anti-HIV Drugs
Completed
525
Beneficial Effects of Antenatal Magnesium Sulfate (BEAM Trial)
1997-12-01
2007-06-01
Completed
2,136
A Study to Access the Safety/Efficacy of Thalidomide in the Treatment of Anemia in Patients With Myelodysplastic Syndromes
2001-08-01
2004-02-01
Completed
220
Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter)
2003-02-01
2007-06-01
Completed
600
Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer
2003-08-25
2021-01-05
Completed
1,381
Efficacy and Safety Study of CC-5013 Monotherapy in Subjects With Myelodysplastic Syndromes
2003-06-01
2007-02-01
Completed
215
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Drexel University College of Medicine" #1 sponsor was "National Cancer Institute (NCI)" with 7 trials, followed by "Celgene" with 5 trials
sponsored, "Boston Scientific Corporation" with 4 trials sponsored, "Gilead Sciences" with 4 trials sponsored and "Knopp Biosciences"
with 4 trials sponsored. Other sponsors include 108 different institutions and
companies that sponsored additional 80 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Drexel University College of Medicine"
#1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 8 trials as a collaborator, "National Cancer Institute (NCI)" with 5 trials as a collaborator, "Pfizer" with 4 trials as a collaborator, "Cystic Fibrosis Foundation" with 3 trials as a collaborator and "National Institute of Allergy and Infectious Diseases (NIAID)" with 3 trials as a collaborator. Other collaborators include 105 different institutions and companies that were
collaborators in the rest 109 trials.
Clinical Trials Conditions at Drexel University College of Medicine
According to Clinical.Site data, the most researched conditions in "Drexel University College of Medicine" are
"Heart Failure" (11 trials), "HIV Infections" (9 trials), "Cystic Fibrosis" (8 trials), "Alzheimer's Disease" (6 trials) and "Amyotrophic Lateral Sclerosis" (6 trials). Many other conditions were trialed in "Drexel University College of Medicine" in a lesser frequency.
Clinical Trials Intervention Types at Drexel University College of Medicine
Most popular intervention types in "Drexel University College of Medicine" are "Drug" (95 trials), "Other" (24 trials), "Device" (19 trials), "Biological" (15 trials) and "Procedure" (9 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (32 trials), "Laboratory Biomarker Analysis" (7 trials), "Quality-of-Life Assessment" (5 trials), "Cisplatin" (3 trials) and "Doxorubicin Hydrochloride" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Drexel University College of Medicine
The vast majority of trials in "Drexel University College of Medicine" are
117 trials for "All" genders and 20 trials for "Female" genders.
Clinical Trials Status at Drexel University College of Medicine
Currently, there are NaN active trials in "Drexel University College of Medicine".
undefined are not yet recruiting,
undefined are recruiting,
12 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 95 completed trials in Drexel University College of Medicine,
undefined suspended trials,
and 22 terminated clinical trials to date.
Out of the total trials that were conducted in Drexel University College of Medicine, 3 "Phase 1"
clinical trials were conducted, 44 "Phase 2" clinical
trials and 66 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 6 trials, and there were
also 11 trials that are defined as “Not Applicable".